Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy
А. В. Куликов, Raul R. Gainetdinov, Evgeni Ponimaskin, et al.
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 4, pp. 319-330
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection
Carlos Castillo-Zacarías, Mario E. Barocio, Enrique Hidalgo-Vázquez, et al.
The Science of The Total Environment (2020) Vol. 757, pp. 143722-143722
Closed Access | Times Cited: 145
Gender Differences in Depression: Evidence From Genetics
Lihong Zhao, Guanghong Han, Yinghao Zhao, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 87
Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem
Н. К. Попова, В. С. Науменко
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 3, pp. 227-239
Closed Access | Times Cited: 84
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 84
When pharmaceutical drugs become environmental pollutants: Potential neural effects and underlying mechanisms
Pascal Vaudin, Corinne Augé‐Gouillou, Nathalie Just, et al.
Environmental Research (2021) Vol. 205, pp. 112495-112495
Open Access | Times Cited: 56
The tryptophan metabolic pathway of the microbiome and host cells in health and disease
Kentaro Miyamoto, Tomohisa Sujino, Takanori Kanai∥
International Immunology (2024)
Open Access | Times Cited: 8
Proximate causes and ultimate effects of common antidepressants, fluoxetine and venlafaxine, on fish behavior
Arash Salahinejad, Anoosha Attaran, Denis Meuthen, et al.
The Science of The Total Environment (2021) Vol. 807, pp. 150846-150846
Closed Access | Times Cited: 53
Control list of high-priority chemicals based on 5-HT-RI functionality and the human health interference effects selective CNN-GRU deep learning model
Peixuan Sun, Wenjin Zhao
The Science of The Total Environment (2024) Vol. 915, pp. 169699-169699
Closed Access | Times Cited: 4
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder
Sudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J. Sniatynski, et al.
Journal of Affective Disorders (2025)
Open Access
Presence and Environmental Risk Assessment of Fluoxetine and Serotonin Hormone in the Istanbul Strait, Türkiye
Güldehan Deryal, Nagihan E. Korkmaz, Abdullah Aksu, et al.
International Journal of Environmental Research (2025) Vol. 19, Iss. 3
Closed Access
Tryptophan hydroxylase 2 as a therapeutic target for psychiatric disorders: focus on animal models
Е. А. Куликова, А. В. Куликов
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 8, pp. 655-667
Closed Access | Times Cited: 41
Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
James Sexton, Charles D. Nichols, Peter S. Hendricks
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 37
Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder
Feifei Ren, Yufeng Ma, Zhu Xiao-chen, et al.
Journal of Affective Disorders (2020) Vol. 273, pp. 254-264
Closed Access | Times Cited: 35
Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression
Melodi A. Bowman, Lynette C. Daws
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 28
The physiology, pathology and potential therapeutic application of serotonylation
Shu‐Heng Jiang, Yahui Wang, Li-Peng Hu, et al.
Journal of Cell Science (2021) Vol. 134, Iss. 11
Open Access | Times Cited: 20
miRNAs in treatment-resistant depression: a systematic review
Lun Cai, Jingwen Xu, Jie Liu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Associations of childhood trauma with remission and treatment response after 12 weeks of selective serotonin reuptake inhibitor treatment in patients with major depressive disorder
Yanzhi Li, Yan Chen, Yingchen Jiang, et al.
General Hospital Psychiatry (2024) Vol. 92, pp. 12-19
Closed Access | Times Cited: 2
A Bibliometric and Visual Analysis of Single Nucleotide Polymorphism Studies in Depression
Zi Zhang, Ye Yang, Wan Kong, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 302-322
Open Access | Times Cited: 6
Tryptophan Hydroxylase 2 Deficiency Modifies the Effects of Fluoxetine and Pargyline on the Behavior, 5-HT- and BDNF-Systems in the Brain of Zebrafish (Danio rerio)
Valentina S. Evsiukova, Д. В. Базовкина, Ekaterina Bazhenova, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12851-12851
Open Access | Times Cited: 14
On the role of serotonin 5-HT1A receptor in autistic-like behavior: сross talk of 5-HT and BDNF systems
Е. М. Кондаурова, Irina I. Belokopytova, Elisabeth A. Kulikova, et al.
Behavioural Brain Research (2022) Vol. 438, pp. 114168-114168
Closed Access | Times Cited: 9
The functional variant rs334558 of <em>GSK3B</em> is associated with remission in patients with depressive disorders
Аnastasia Levchenko, Innokentiy S. Losenkov, N. Vyalova, et al.
Pharmacogenomics and Personalized Medicine (2018) Vol. Volume 11, pp. 121-126
Open Access | Times Cited: 15
The interplay of serotonin 5-HT1A and 5-HT7 receptors in chronic stress
Monika Bijata, Alexander Wirth, Jakub Włodarczyk, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 19
Open Access | Times Cited: 1
GPCR oligomerization as a target for antidepressants: Focus on GPR39
Katarzyna Młyniec, Dominika Siodłak, Urszula Doboszewska, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107842-107842
Closed Access | Times Cited: 10
Neuronal nitric oxide synthase inhibition accelerated the removal of fluoxetine’s anxiogenic activity in an animal model of PTSD
Mohammad Amin Sadeghi, Sara Hemmati, Hasan Yousefi‐Manesh, et al.
Behavioural Brain Research (2022) Vol. 437, pp. 114128-114128
Closed Access | Times Cited: 7
Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease
Joana Pereira-Sousa, Bruna Ferreira-Lomba, Aina Bellver‐Sanchís, et al.
Neurobiology of Disease (2021) Vol. 152, pp. 105278-105278
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top